BDBM445221 US10669235, Example 12

SMILES: COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)NCCN3CCC(O)CC3)c3ccccc3)c2cc1C

InChI Key: InChIKey=WJTZIBDSNXVBCN-ZIADKAODSA-N

Data: 6 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 445221   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human))	BDBM445221 (US10669235, Example 12) Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)NCCN3CCC(O)CC3)c3ccccc3)c2cc1C Show InChI InChI=1S/C32H34N4O5/c1-20-18-26-27(19-25(20)32(40)41-2)35-31(39)28(26)29(21-6-4-3-5-7-21)34-23-10-8-22(9-11-23)30(38)33-14-17-36-15-12-24(37)13-16-36/h3-11,18-19,24,34,37H,12-17H2,1-2H3,(H,33,38)(H,35,39)/b29-28-	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	6.38	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against VEGFR2 (VEGFR2 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR2 pr...				US Patent US10669235 (2020)
					More data for this Ligand-Target Pair
Platelet-derived growth factor receptor beta (Homo sapiens (Human))	BDBM445221 (US10669235, Example 12) Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)NCCN3CCC(O)CC3)c3ccccc3)c2cc1C Show InChI InChI=1S/C32H34N4O5/c1-20-18-26-27(19-25(20)32(40)41-2)35-31(39)28(26)29(21-6-4-3-5-7-21)34-23-10-8-22(9-11-23)30(38)33-14-17-36-15-12-24(37)13-16-36/h3-11,18-19,24,34,37H,12-17H2,1-2H3,(H,33,38)(H,35,39)/b29-28-	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	8.75	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against PDGFRβ (PDGFRβ Kinase Enzyme System: Promega), were evaluated by mixing the...				US Patent US10669235 (2020)
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 3 (Homo sapiens (Human))	BDBM445221 (US10669235, Example 12) Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)NCCN3CCC(O)CC3)c3ccccc3)c2cc1C Show InChI InChI=1S/C32H34N4O5/c1-20-18-26-27(19-25(20)32(40)41-2)35-31(39)28(26)29(21-6-4-3-5-7-21)34-23-10-8-22(9-11-23)30(38)33-14-17-36-15-12-24(37)13-16-36/h3-11,18-19,24,34,37H,12-17H2,1-2H3,(H,33,38)(H,35,39)/b29-28-	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	11.5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against FGFR3 (FGFR3 Kinase Enzyme System: Promega), were evaluated by mixing the FGFR3 prote...				US Patent US10669235 (2020)
					More data for this Ligand-Target Pair
Platelet-derived growth factor receptor alpha (Homo sapiens (Human))	BDBM445221 (US10669235, Example 12) Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)NCCN3CCC(O)CC3)c3ccccc3)c2cc1C Show InChI InChI=1S/C32H34N4O5/c1-20-18-26-27(19-25(20)32(40)41-2)35-31(39)28(26)29(21-6-4-3-5-7-21)34-23-10-8-22(9-11-23)30(38)33-14-17-36-15-12-24(37)13-16-36/h3-11,18-19,24,34,37H,12-17H2,1-2H3,(H,33,38)(H,35,39)/b29-28-	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	14.2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against PDGFRα (PDGFRα Kinase Enzyme System: Promega), were evaluated by mixing the...				US Patent US10669235 (2020)
					More data for this Ligand-Target Pair
Fibroblast growth factor receptor 1 (Homo sapiens (Human))	BDBM445221 (US10669235, Example 12) Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)NCCN3CCC(O)CC3)c3ccccc3)c2cc1C Show InChI InChI=1S/C32H34N4O5/c1-20-18-26-27(19-25(20)32(40)41-2)35-31(39)28(26)29(21-6-4-3-5-7-21)34-23-10-8-22(9-11-23)30(38)33-14-17-36-15-12-24(37)13-16-36/h3-11,18-19,24,34,37H,12-17H2,1-2H3,(H,33,38)(H,35,39)/b29-28-	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	22.4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against FGFR1 (FGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the FGFR1 prote...				US Patent US10669235 (2020)
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 1 (Homo sapiens (Human))	BDBM445221 (US10669235, Example 12) Show SMILES COC(=O)c1cc2NC(=O)\C(=C(/Nc3ccc(cc3)C(=O)NCCN3CCC(O)CC3)c3ccccc3)c2cc1C Show InChI InChI=1S/C32H34N4O5/c1-20-18-26-27(19-25(20)32(40)41-2)35-31(39)28(26)29(21-6-4-3-5-7-21)34-23-10-8-22(9-11-23)30(38)33-14-17-36-15-12-24(37)13-16-36/h3-11,18-19,24,34,37H,12-17H2,1-2H3,(H,33,38)(H,35,39)/b29-28-	PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	61.9	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
RESPIVERT LIMITED US Patent					Assay Description The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...				US Patent US10669235 (2020)
					More data for this Ligand-Target Pair